Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP
Filters
Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP
United Arab Emirates
Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP
20172018
Reported cefixime resistance in gonorrhea by country in 2016 (proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP)
In 2016, Myanmar had the highest value (66.67) among 9 countries.
| # | Country | Value | Change |
|---|---|---|---|
| 1 | Myanmar | 66.67 | – |
| 1 | Cyprus (2018) | 20 | – |
| 2 | Saudi Arabia (2018) | 16.67 | – |
| 2 | India | 6.33 | – |
| 3 | Belarus (2018) | 15.8 | -28.8% |
| 3 | Pakistan | 0 | – |
Similar Datasets
Proportion of isolates with resistance to ciprofloxacin reported to WHO-GASP
WHO (GASPRSCIP)
Proportion of isolates with resistance to azithromycin reported to WHO-GASP
WHO (GASPRSAZM)
Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials testing in Neisseria gonorrhoea isolates (WHO-GASP) (number)
WHO (GASP_ISOLATESTESTED_NUMBER)
Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP
WHO (GASPRSCRO)